EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS023-07050 
Organism
Homo sapiens 
Tissue/cell
CD8+ 
Coordinate
chr13:111377710-111379620 
Target genes
Number: 3             
NameEnsembl ID
TF binding sites/motifs
Number: 5             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
Foxd3MA0041.1chr13:111378330-111378342GTTTGTTTGTTT+6.32
Nr2f6(var.2)MA0728.1chr13:111378548-111378563TGAACTCCTGACCTC-6.22
PLAG1MA0163.1chr13:111379208-111379222GAGGCCCAAGGGTG+6.31
SNAI2MA0745.2chr13:111379341-111379351TGCACCTGTT-6.02
ZfxMA0146.2chr13:111378573-111378587CCCGCCTCGGCCTC+6.01
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_19894chr13:111378585-111379591CD4p_CD25-_Il17p_PMAstim_Th17
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr13111378707111379593
chr13111379072111379409
Number: 1             
IDChromosomeStartEnd
GH13I110726chr13111378642111379588
Enhancer Sequence
ATTTTCTACG AAACAAGAAA ATGCTTGTTT CAGCAGGCAA CTTTAAATAA AGGTACTCAG 60
TGTCGTGGTG TATGTATATC AATATAGCCA CCATTTATTG CCTCCTATAT GCTAGACATT 120
GCTAGCACTG CATACTTCAT ATTTTATGAC AACCCTGCCA AAAAATGGCT GCTTTTCCTG 180
ATGAAGGTGC TGAGACTCCA GCCAGGGACC TGACTTGCAC AAGGCCAACG CCCTGCATCT 240
GGCTCCAAAA CCAGCATCCT TGACCACCGC CTGGCACCCG GAGGCCTCCT CATGGTCAGG 300
ACCTGGCGTT GCTGCTGGTC TTCCCTGAAC GCCTAACATG CCAGGAGTGT GCTGTCCTCC 360
CAGCTCTGTG GGGGTCTTAC AACTGAGAAA GCCATAGAAG GTGAAAGAAA CGCTCATGGT 420
CTCACGGGAG GAGAGAGCGA AAAAGTCTTA ATTGCTGGGC TTCTTTGCCT GAATGAAGGG 480
ATCTGCAGGA GCCACGGGTA TTTGCACTAC CAAGTTCTCA TGCTTCTGAT TTTCCTCCAG 540
GTAAACCAGG ATGCTTACTT CAAGTTTCTT GTTTTGCCCT ACAGTGAATT TTAGGATTGT 600
AATTTACCTG CAAGGTTTTT GTTTGTTTGT TTTGTTTTGT TTTTTCGAGA TGGAGTTTCG 660
CCCAAGCTGG AGTGCAATGG CGCAATCTCT GCTCACTGCA ACCTTCGCCT CCCGGGTTCA 720
AGCAATTCTC CTGCGTTAGC CACCCGAGTA GCTGGGATTA CAGGCACGCG CCACCACACC 780
TGGCTAATTT TGTATTTTTA GTAGAGACGG GGTTTCTCCA TGTTGGTGAG GCTGGTCTTG 840
AACTCCTGAC CTCAGGTGAT CCGCCCGCCT CGGCCTCCCA AAGTACTGGG ATTACAGGCA 900
TGAGCCACCG TGCCCAGCCT ACCTGCAAGG TTTTAAGCAA TTCACTAGGA GCCATGCACG 960
GTGCTAGAAT CAGCATGAGA GTCAAAGTCA GATTTGAATC AGGACTAGTT TATCACAGGT 1020
TAACCTCAAG GAAGTCACTC TTCTGTACCC AATGTTCTCA GAAGCAAAAT AAGGACAGTG 1080
ATAATGCCCA TCCCAGGAGT GGAGGCCCAG ACTTGTTAAT GTCTGAAAAT ACTTCAGAAA 1140
TGCTAGAGCA CTGTACAGAT AACAATTTGA GTAATATTTT TGGTCAAATT ATTCTAGTTT 1200
AACACATGTA TTCTTAAAAA ATGGACTTGT GATTCCTTAC AGCTAAAGAG AATCAAGTCC 1260
ACCCTTAGCA TGTTAGCGGT CACTGCCAGG TTCCTGCTGC ACGAGGAGGA AGTCCTCCAT 1320
GGCTGCTTTT CTATAAACAA TTCCATTTCT CGTTGTAGAA CACAGAAGTA AATACATCGA 1380
ATTTTTATTT TTAGTAGCAA TCAGAGCCTA CTAAACTTCC TTTTGACTCA CCTCTTGATT 1440
GAATTCAGAG TAGGCAGAAA ATCTCATTCA ATCTCTTCAC TGTGTGGGTG AGGAAACCGA 1500
GGCCCAAGGG TGATGAAGCC ACTTCCTCAA AGGCACTCCG TGAGTTGGTG GTGGGGCTGC 1560
CGGCAGGATG AAGTGCTGTT ACTCCAGGCC AGAGCCACTC CCCCGCTTCA TCAGCCATGC 1620
TGTTTCATGG GTGCACCTGT TCTCATTTAT GTGGACGTTA GGAACCGTGG GTCTCTCGTG 1680
TTAAGCCATA GGCCTTTAAT AAAGACGTGT AGAGTAAAGC CTGAATCCAA GAATTGACAT 1740
TTAAACATGA AACATTTTCT TTTCTAACTT GGAAACCAGT TCTAAAAACA CACCTAAAAG 1800
GGAATTTCAG TTTGATTTGT GTGAAGGGAA TATTTTTGGA TAAATCTGTA TGCCATTGGA 1860
AATGCAATAT TTCTAAATGA TTAATATTTG AGACATTAAT GTAATGAGAC 1910